國立高雄大學圖資館 |

Language: English

Back

Sigma proteinsevolution of the conce...

Kim, Felix J.

Sigma proteinsevolution of the concept of Sigma receptors /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Sigma proteinsedited by Felix J. Kim, Gavril W. Pasternak.
Reminder of title:	evolution of the concept of Sigma receptors /
other author:	Kim, Felix J.
Published:	Cham :Springer International Publishing :2017.
Description:	viii, 330 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Sigma receptors.
Online resource:	http://dx.doi.org/10.1007/978-3-319-65853-7
ISBN:	9783319658537$q(electronic bk.)

Sigma proteinsevolution of the concept of Sigma receptors /
Sigma proteinsevolution of the concept of Sigma receptors /[electronic resource] :edited by Felix J. Kim, Gavril W. Pasternak. - Cham :Springer International Publishing :2017. - viii, 330 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2440171-2004 ;. - Handbook of experimental pharmacology ;208..

Preface -- Historical perspective and background - including Sigma protein subtypes and ligand selectivity -- Sigma imaging agents -- Medicinal chemistry -- 3-dimensional homology models of Sigma1 -- Neuronal plasticity and ion channels -- Opioid receptors and other GPCR -- Cancer -- Neurodegenerative diseases -- Pain -- Cognition, learning, neurological disorders -- Drug abuse and addiction -- Alcohol Abuse -- Stroke and neuroprotection.

Two sigma receptor subtypes have been proposed, sigma1 and 2. Much of our understanding of this system is based on biochemical and pharmacological characterization of the cloned sigma1 receptor subtype (Sigma1) It has become clear that sigma receptors are not canonical receptors. Sigma1 is highly conserved among mammalian species, however, it does not share significant homology with any other mammalian protein. Although a range of structurally diverse small molecules bind Sigma1 with high affinity, and it has been associated with a broad range of signaling systems, Sigma1 itself has no known signaling or enzymatic activity. The evolution of this field over nearly four decades has more recently led to a fundamental shift in the concept of "sigma receptors" to what may more accurately and generally be called sigma proteins. Largely based on traditional pharmacologic approaches, the Sigma1 protein has been associated with a broad range of signaling systems, including G-protein coupled receptors, NMDA receptors, and ion channels. Sigma proteins have been linked to a range of physiological processes, including intracellular calcium signaling, neuroprotection, learning, memory, and cognition. Emerging genetic, clinical, and mechanism focused molecular pharmacology data demonstrate the involvement of proteins in a range of pathophysiologies and disorders including neurodegenerative disease, pain, addiction, psychomotor stimulant abuse, and cancer. However, an understanding of the physiological role of sigma proteins has remained elusive. Emerging data associate Sigma1 with chaperone-like activities or molecular scaffold functions. This book aims to provide an updated perspective on this rapidly evolving field undergoing changes in fundamental concepts of key importance to the discipline of pharmacology. It focusses on the reported roles of sigma proteins in pathophysiology and on emergent therapeutic initiatives.

ISBN: 9783319658537$q(electronic bk.)

Standard No.: 10.1007/978-3-319-65853-7doiSubjects--Topical Terms:

775162
Sigma receptors.

LC Class. No.: RM301.41

Dewey Class. No.: 615.19

Sigma proteinsevolution of the concept of Sigma receptors /
LDR:03430nmm a2200325 a 4500 001 523275
003 DE-He213
005 20180419105130.0
006 m d
007 cr nn 008maaau
008 180628s2017 gw s 0 eng d
020 $a 9783319658537$q(electronic bk.)
020 $a 9783319658513$q(paper)
024 7 $a 10.1007/978-3-319-65853-7 $2 doi
035 $a 978-3-319-65853-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.41
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 615.19 $2 23
090 $a RM301.41 $b .S577 2017
245 0 0 $a Sigma proteins $h [electronic resource] : $b evolution of the concept of Sigma receptors / $c edited by Felix J. Kim, Gavril W. Pasternak.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a viii, 330 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.244
505 0 $a Preface -- Historical perspective and background - including Sigma protein subtypes and ligand selectivity -- Sigma imaging agents -- Medicinal chemistry -- 3-dimensional homology models of Sigma1 -- Neuronal plasticity and ion channels -- Opioid receptors and other GPCR -- Cancer -- Neurodegenerative diseases -- Pain -- Cognition, learning, neurological disorders -- Drug abuse and addiction -- Alcohol Abuse -- Stroke and neuroprotection.
520 $a Two sigma receptor subtypes have been proposed, sigma1 and 2. Much of our understanding of this system is based on biochemical and pharmacological characterization of the cloned sigma1 receptor subtype (Sigma1) It has become clear that sigma receptors are not canonical receptors. Sigma1 is highly conserved among mammalian species, however, it does not share significant homology with any other mammalian protein. Although a range of structurally diverse small molecules bind Sigma1 with high affinity, and it has been associated with a broad range of signaling systems, Sigma1 itself has no known signaling or enzymatic activity. The evolution of this field over nearly four decades has more recently led to a fundamental shift in the concept of "sigma receptors" to what may more accurately and generally be called sigma proteins. Largely based on traditional pharmacologic approaches, the Sigma1 protein has been associated with a broad range of signaling systems, including G-protein coupled receptors, NMDA receptors, and ion channels. Sigma proteins have been linked to a range of physiological processes, including intracellular calcium signaling, neuroprotection, learning, memory, and cognition. Emerging genetic, clinical, and mechanism focused molecular pharmacology data demonstrate the involvement of proteins in a range of pathophysiologies and disorders including neurodegenerative disease, pain, addiction, psychomotor stimulant abuse, and cancer. However, an understanding of the physiological role of sigma proteins has remained elusive. Emerging data associate Sigma1 with chaperone-like activities or molecular scaffold functions. This book aims to provide an updated perspective on this rapidly evolving field undergoing changes in fundamental concepts of key importance to the discipline of pharmacology. It focusses on the reported roles of sigma proteins in pathophysiology and on emergent therapeutic initiatives.
650 0 $a Sigma receptors. $3 775162
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Neurosciences. $3 211508
650 2 4 $a Human Physiology. $3 274509
650 2 4 $a Human Genetics. $3 273658
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Kim, Felix J. $3 794379
700 1 $a Pasternak, Gavril W. $3 509610
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-65853-7
950 $a Biomedical and Life Sciences (Springer-11642)